Product Program year 2025 Source: CMS Open Payments

Surgiphor

Device Cell Analyzers

PDI 00382909101102

Open in the dashboard

General payments

$56,304

503 payments

Research payments

$0

0 payments

Through program year 2025, $56,304 in general payments and $0 in research payments were reported against Surgiphor (Cell Analyzers).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $50,770 500
2024 General $5,534 3

Breakdown

Who paid General payments · program years 2024–2025
  1. Davol Inc. $38,125 360 payments
  2. Becton, Dickinson and Company $13,891 142 payments
  3. C. R. Bard, Inc. & Subsidiaries $4,288 1 payment
Top recipients General payments · program year 2025
  1. Javad Parvizi Adult Reconstructive Orthopaedic Surgery · Philadelphia, PA $3,547 7% · 14 payments
  2. Carlos Higuera Rueda Orthopaedic Surgery · Weston, FL $778 2% · 2 payments
  3. Matthew Menard Vascular Surgery · Boston, MA $750 1% · 1 payment
  4. Richard Glunk Plastic Surgery · King Of Prussia, PA $750 1% · 1 payment
  5. Mercedes Vondeck Orthopaedic Surgery · Cambridge, MA $750 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $9,878 20% · 86 practitioners
  2. Adult Reconstructive Orthopaedic Surgery Orthopaedic Surgery $5,526 11% · 21 practitioners
  3. Surgery $4,901 10% · 39 practitioners
  4. Plastic Surgery $3,954 8% · 24 practitioners
  5. Physician Assistant $3,719 7% · 63 practitioners

The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $12,693 25% · 46 recipients
  2. Georgia $5,914 12% · 46 recipients
  3. Massachusetts $5,276 10% · 14 recipients
  4. New Jersey $4,398 9% · 33 recipients
  5. Texas $4,024 8% · 81 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

503 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record